Navigation Links
Vermillion Reports Results for Third Quarter 2011
Date:11/9/2011

vel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Additional information about Vermillion can be found at www.vermillion.com.

Forward-Looking StatementCertain matters discussed in this press release contain forward-looking statements that involve significant risks and uncertainties, including statements regarding Vermillion's plans, objectives, expectations and intentions. These forward-looking statements are based on Vermillion's current expectations. The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for such forward-looking statements. In order to comply with the terms of the safe harbor, Vermillion notes that a variety of factors could cause actual results and experience to differ materially from the anticipated results or other expectations expressed in such forward-looking statements. Factors that could cause actual results to materially differ include but are not limited to: (1) uncertainty as to Vermillion's ability to protect and promote its proprietary technology; (2) Vermillion's lack of a lengthy track record successfully developing and commercializing diagnostic products; (3) uncertainty as to whether Vermillion will be able to obtain any required regulatory approval of its future diagnostic products; (4) uncertainty of the size of market for its existing diagnostic tests or future diagnostic products, including the risk that its products will not be competitive with products offered by other companies, or that patients will not be able to receive reimbursement for Vermillion's tests from third party payors such as private insurance companies and government insurance plans; (5) uncertainty whether Vermillion will successfully license or otherwise successfully partner with third par
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Vermillion to Present at Stephens Fall Investment Conference on November 16, 2011
2. Vermillion Engages Liolios Group to Lead Investor Relations Program
3. Vermillion Enhances Management Team With A Key Addition
4. Vermillion Appoints Distribution Partner for OVA1® in Israel and the Palestine Territories
5. Vermillion Reports Financial Results for the First Quarter 2011
6. Vermillion Announces Presentation of Positive Ovarian Biomarker Data for Next Generation Test
7. Vermillion Attends 42nd Annual Meeting of the Society of Gynecologic Oncologists
8. Vermillion to Present at the Roth 23rd Annual OC Growth Stock Conference March 13-16, 2011, Laguna Niguel, CA
9. Vermillion Announces $21.8 Million Public Offering
10. Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Fourth Quarter 2010
11. Vermillion Announces Issuance of Patent for Peripheral Artery Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... JOLLA, Calif. , June 1, 2015 /PRNewswire/ ... ), a biopharmaceutical company leading the discovery and ... that Kleanthis G. Xanthopoulos , Ph.D. has ... as a member of Regulus, Board of Directors, ... biotechnology industry.  Paul Grint, M.D., who previously served ...
(Date:6/1/2015)... DURHAM, N.C. , June 1, 2015  bioMérieux, ... vitro diagnostics, has been invited to join the ... of antibiotic use in the U.S. as a means ... various sectors, will gather tomorrow, June 2, 2015, to ... next five years to slow the emergence of antibiotic-resistant ...
(Date:6/1/2015)... June 1, 2015 Select Medical Holdings Corporation ... Corporation, a joint venture that Select Medical Corporation ("Select") ... completed its previously announced acquisition of Concentra Inc.  Cressey ... venture. About Select Medical Corporation ... hospitals and outpatient rehabilitation clinics in the ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 2Select Medical Holdings Corporation Announces Completion of Acquisition of Concentra Inc. through Joint Venture with Welsh Carson 3
... Dec. 22, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech Holdings ... 910801.TW), China,s leading integrated healthcare enterprise, today announced that ... market, accumulating a total of 36,976,000 shares in December ... shares at a weighted average price of HK$0.83 per ...
... question confronting neuroscientists and computer vision researchers alike is how ...  Introspectively, we know that the human brain solves this problem ... know what it is. But teaching a computer ... research published this fall in the Public Library of ...
Cached Medicine Technology:Golden Meditech Further Repurchases Shares 2Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 2Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 3Do You See What I See: Scientists Model Brain Structure To Help Computers Recognize Objects 4
(Date:6/2/2015)... Cincinnati, OH (PRWEB) June 02, 2015 ... healthcare ministry serving Ohio and Kentucky – has devoted ... Be Well videos to skin cancer prevention. One in ... concise video on Mercy Health’s YouTube channel, a Mercy ...     What are the main causes of skin cancer? ...
(Date:6/2/2015)... 02, 2015 First Choice Emergency ... rooms in the United States, named Kenneth Alan Totz, ... Jones Road facility. , “We are pleased to ... Road facility,” said Dr. James M. Muzzarelli, Executive Medical ... Totz received his undergraduate degree from St. Edwards University ...
(Date:6/2/2015)... Colleen’s Dream Foundation , with fundraising help from ... to support ovarian cancer research conducted by Cheng Wang, Ph.D. ... Colleen’s Dream Foundation Board of Directors. , Cundiff says the ... Colleen’s Dream Foundation and they couldn’t have picked a better ... a rising star in the ovarian cancer world,” says Cundiff. ...
(Date:6/2/2015)... (PRWEB) June 02, 2015 While the ... adaptions of comic books, comic books themselves are stepping ... Comics Uniting Nations plans to produce educational comics in ... Global Goals for Sustainable Development - an international effort ... poverty, hunger, health, education, sustainable energy, inequality, climate change ...
(Date:6/2/2015)... Barbara, CA (PRWEB) June 02, 2015 ... a scholarship fund set up by current and former ... Odajnyk, a beloved faculty member from 2002 until his ... integrity, keen intelligence, and depth of feeling, as well ... and fairytales. His capacities as an analyst, teacher, and ...
Breaking Medicine News(10 mins):Health News:Video provides helpful information about skin cancer prevention 2Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3Health News:Can Comics Help the United Nations Save the World? 2Health News:Can Comics Help the United Nations Save the World? 3Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 2Health News:Pacifica Graduate Institute - Mythological Studies Students Establish Memorial Scholarship to Honor Dr. V. Walter Odajnyk 3
... to researchers from Wake Forest University School of ... restlessness associated with dementia are found to increase ... over-burdened or depressed. ,‘These symptoms are part ... them, but certain styles of caregiving may bring ...
... treatment methods for asthma attacks are found to be ... shows//. Spacer plays shorter stays in emergency departments usually ... Christopher Cates, M.D., of the University of Alberta, in ... children ages 2 years and older, and 614 adults ...
... resident doctors of Indira Gandhi Medical College, Shimla and ... light procession in protest against reservation to other backward ... and doctors also organized a blood donation camp in ... parallel OPDs. The medicos vowed to continue their struggle ...
... Prime Minister Manmohan Singh's appeal, the stalemate between government ... doctors persisted with their hunger strike for the tenth ... quo and we will continue our strike as government ... experts to review the reservation policy,' Dr Vinod Patro, ...
... brain tissue is possible in individuals exposed to lead after 18 ... of the American Academy of Neurology, May 23 2006. ,The ... had not been exposed to lead for an average of 18 ... of more than eight years. ,The researchers measured the ...
... eyesight to juvenile diabetes, has managed to urge scientists and ... her and thousands like herself to see despite failing visual ... was examined with a scanning laser ophthalmoscope, when she was ... a few years. "For a poet, that's an incredible feeling," ...
Cached Medicine News:Health News:Symptoms In Dementia Patients Negatively Correlates With The Characteristics Of Caregivers 2Health News:Spacers Score Over Nebulizers in Childhood Asthma Treatment 2Health News:Loss and damage to the brain cells possible with lead exposure in years ahead 2
Inquire...
...
Liquichek Elevated CRP Control is a liquid assayed serum control with elevated levels of C-Reactive Protein....
LiquichekCardiac Markers Plus Control LT is a premium, comprehensive cardiac assessment control with many analytes and long stability....
Medicine Products: